Aster DM Quality Care Q2 FY27: revenue Rs 2,829.00 cr, normalised PAT Rs 281.00 cr
For Q2 FY27, Aster DM Quality Care reported revenue from operations of Rs 2,829.00 cr and normalised PAT of Rs 281.00 cr, up from Rs 2,382.00 cr and Rs 210.00 cr in Q2 FY26.
Key takeaways
- Revenue from operations rose to Rs 2,829.00 cr in Q2 FY27 from Rs 2,382.00 cr in Q2 FY26.
- Operating EBITDA increased to Rs 678.00 cr in Q2 FY27 versus Rs 545.00 cr in Q2 FY26.
- Operating EBITDA margin was 24.0% in Q2 FY27 compared with 22.9% in Q2 FY26.
- Profit before tax was Rs 446.00 cr in Q2 FY27 against Rs 374.00 cr in Q2 FY26.
- Normalised PAT reached Rs 281.00 cr in Q2 FY27 versus Rs 210.00 cr in Q2 FY26.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 2,829.00 cr | Rs 2,382.00 cr | +18.8% |
| PAT | Rs 281.00 cr | Rs 210.00 cr | +33.8% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 9.93% of revenue, up 111 bps from 8.82%.
• Basis: Consolidated, Profit and Loss Statement in the statement of financial results for Q2 FY27 vs Q2 FY26.
• Revenue from operations (Q2 FY27): Rs 2,829.00 cr
Revenue from operations (Q2 FY26): Rs 2,382.00 cr
• Operating EBITDA (Q2 FY27): Rs 678.00 cr
Operating EBITDA (Q2 FY26): Rs 545.00 cr
• Operating EBITDA margin (%) (Q2 FY27): 24.0%
Operating EBITDA margin (%) (Q2 FY26): 22.9%
• EBITDA post INDAS (Q2 FY27): Rs 663.00 cr
EBITDA post INDAS (Q2 FY26): Rs 520.00 cr
• EBITDA post INDAS margin (%) (Q2 FY27): 23.4%
EBITDA post INDAS margin (%) (Q2 FY26): 21.9%
• Profit before tax (Q2 FY27): Rs 446.00 cr
Profit before tax (Q2 FY26): Rs 374.00 cr
• PBT margin (%) (Q2 FY27): 15.8%
PBT margin (%) (Q2 FY26): 15.7%
• Normalised PAT (Q2 FY27): Rs 281.00 cr
Normalised PAT (Q2 FY26): Rs 210.00 cr
• Normalised PAT margin (Q2 FY27): 9.9%
Normalised PAT margin (Q2 FY26): 8.8%
For the quarter ended 30 September 2026 (Q2 FY27), Aster DM Quality Care Limited’s consolidated Profit and Loss Statement in the statement of financial results shows revenue from operations of Rs 2,829.00 cr, compared with Rs 2,382.00 cr in the corresponding quarter a year earlier (Q2 FY26). Operating EBITDA for Q2 FY27 is reported at Rs 678.00 cr versus Rs 545.00 cr in Q2 FY26, with the operating EBITDA margin rising from 22.9% to 24.0% over the same period.
EBITDA post INDAS for Q2 FY27 stands at Rs 663.00 cr, up from Rs 520.00 cr in Q2 FY26, and the EBITDA post INDAS margin moves from 21.9% to 23.4%. Profit before tax increases to Rs 446.00 cr in Q2 FY27 from Rs 374.00 cr in Q2 FY26, with the PBT margin shown at 15.8% for Q2 FY27 versus 15.7% for Q2 FY26 in the same Profit and Loss Statement.
Normalised PAT for the quarter, as presented in the Profit and Loss Statement, is Rs 281.00 cr for Q2 FY27 compared with Rs 210.00 cr for Q2 FY26. The corresponding normalised PAT margin is reported at 9.9% for Q2 FY27 against 8.8% for Q2 FY26. These figures are all drawn directly from the consolidated Profit and Loss Statement section of the statement of financial results in the investor presentation.
Track Aster DM Healthcare Ltd
Cruxal reads every Aster DM Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
